Pharmaceutical compositions for treating arthritis and inflammatory disease

   
   

The biological effects of the cytokine TNF are mediated by binding to receptors on the surface of cells. This disclosure describes new proteins and polynucleotides that promote enzymatic cleavage and release of TNF receptors. Also provided are methods for identifying additional compounds that influence TNF receptor shedding. As the active ingredient in a pharmaceutical composition, the products of this invention increase or decrease TNF signal transduction, thereby alleviating the pathology of disease.

 
Web www.patentalert.com

< Compound for the treatment of metabolic disorders

< Method of using punicic acid to enhance immune response and prevent metabolic disorders

> Methods and compositions for the attenuation and/or prevention of stress/catabolic responses

> Aminoalcohol derivatives as beta-3 adrenergic receptor agonists

~ 00177